(Q34499287)

2 August 2017

title

Does pioglitazone prevent macrovascular events in patients with type 2 diabetes? (English)

1 reference

2 August 2017

1 reference

Hertzel C Gerstein

3

0 references

author name string

Rajesh Hiralal

series ordinal

1

1 reference

2 August 2017

Karen K Y Koo

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Canadian Medical Association Journal

2 August 2017

published in

1 reference

2 August 2017

volume

174

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

1090-1091

1 reference

Pioglitazone initiation and subsequent hospitalization for congestive heart failure

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1421458

PubMed Central

reference URL

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1421458

PubMed Central

reference URL

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1421458

PubMed Central

reference URL

27 October 2018

Identifiers

DOI

10.1503/CMAJ.060049

1 reference

2 August 2017

1 reference

2 August 2017

1 reference